iCAD, Inc. (ICAD)

Market Cap	105.59M
Revenue (ttm)	19.53M +8.9%
Net Income	-5.23M
EPS	-0.20
Shares Out	27.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190,127
Open	3.740
Previous Close	3.730
Day's Range	3.710 - 3.880
52-Week Range	1.190 - 4.015
Beta	1.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2025

About ICAD

iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company’s ProFound Breast Health Suite offers solutions for breast cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Detection solutions include advanced artificial intelligence and image analysis workflow solu...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 3, 1986
• Employees: 66
• Stock Exchange: NASDAQ
• Ticker Symbol: ICAD
• Website: https://www.icadmed.com

Financial Performance

In 2024, iCAD, Inc.'s revenue was $19.61 million, an increase of 13.22% compared to the previous year's $17.32 million. Losses were -$5.62 million, 15.9% more than in 2023.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jan 1, 2000

Data Sources Report a data error